Does MOBOCERTINIB Cause Malignant neoplasm progression? 39 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Malignant neoplasm progression have been filed in association with MOBOCERTINIB. This represents 5.5% of all adverse event reports for MOBOCERTINIB.
39
Reports of Malignant neoplasm progression with MOBOCERTINIB
5.5%
of all MOBOCERTINIB reports
15
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From MOBOCERTINIB?
Of the 39 reports, 15 (38.5%) resulted in death, 6 (15.4%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOBOCERTINIB. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does MOBOCERTINIB Cause?
Diarrhoea (309)
Death (160)
Rash (106)
Non-small cell lung cancer (96)
Nausea (85)
Decreased appetite (80)
Lung neoplasm malignant (74)
Vomiting (74)
Fatigue (66)
Asthenia (56)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which MOBOCERTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
MOBOCERTINIB vs MOCLOBEMIDE
MOBOCERTINIB vs MODAFINIL
MOBOCERTINIB vs MOGAMULIZUMAB
MOBOCERTINIB vs MOGAMULIZUMAB-KPKC
MOBOCERTINIB vs MOLNUPIRAVIR